166 related articles for article (PubMed ID: 2111949)
1. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel.
Hatz C; Mayombana C; de Savigny D; MacPherson CN; Koella JC; Degrémont A; Tanner M
Trans R Soc Trop Med Hyg; 1990; 84(1):84-8. PubMed ID: 2111949
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
Barda B; Coulibaly JT; Hatz C; Keiser J
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
[TBL] [Abstract][Full Text] [Related]
3. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania.
Hatz CF; Vennervald BJ; Nkulila T; Vounatsou P; Kombe Y; Mayombana C; Mshinda H; Tanner M
Am J Trop Med Hyg; 1998 Nov; 59(5):775-81. PubMed ID: 9840596
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of praziquantel drug against Schistosoma haematobium and performance of urine reagent strips among pre-and-school aged children during the high transmission season in North-Western Tanzania.
Mazigo HD; Kayange N; Ambrose EE; Zinga MM; Mugassa S; Ruganuza D; Mwingira UJ; Uisso C; Mutapi F
Acta Trop; 2024 Aug; 256():107232. PubMed ID: 38729329
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
[TBL] [Abstract][Full Text] [Related]
6. Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein.
Stecher CW; Fofana HKM; Madsen H; Wilson S; Keita AD; Landouré A; Traoré MS; Vennervald BJ; Reimert CM; Sacko M
Trans R Soc Trop Med Hyg; 2017 Jul; 111(7):316-324. PubMed ID: 29165707
[TBL] [Abstract][Full Text] [Related]
7. Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya.
Kahama AI; Odek AE; Kihara RW; Vennervald BJ; Kombe Y; Nkulila T; Hatz CF; Ouma JH; Deelder AM
Am J Trop Med Hyg; 1999 Aug; 61(2):215-9. PubMed ID: 10463669
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel.
Laurent C; Lamothe F; Develoux M; Sellin B; Mouchet F
Trop Med Parasitol; 1990 Jun; 41(2):139-42. PubMed ID: 2116659
[TBL] [Abstract][Full Text] [Related]
10. Reversibility of urinary tract abnormalities due to Schistosoma haematobium infection.
Doehring E; Ehrich JH; Bremer HJ
Kidney Int; 1986 Oct; 30(4):582-5. PubMed ID: 3097374
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound Evolution of Pediatric Urinary Schistosomiasis after Treatment with Praziquantel in a Highly Endemic Area.
Bocanegra C; Pintar Z; Mendioroz J; Serres X; Gallego S; Nindia A; Aznar ML; Soriano-Arandes A; Salvador F; Gil E; Sikaleta N; Moreno M; Molina I
Am J Trop Med Hyg; 2018 Oct; 99(4):1011-1017. PubMed ID: 30141396
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonography of ureteric abnormalities induced by Schistosoma haematobium infection before and after praziquantel treatment.
Kardorff R; Traoré M; Doehring-Schwerdtfeger E; Vester U; Ehrich JH
Br J Urol; 1994 Dec; 74(6):703-9. PubMed ID: 7827837
[TBL] [Abstract][Full Text] [Related]
13. Morbidity induced by Schistosoma haematobium infections, as assessed by ultrasound before and after treatment with praziquantel, in a recently expanded focus (Senegal River basin).
Delegue P; Picquet M; Shaw DJ; Vercruysse J; Sambou B; Ly A
Ann Trop Med Parasitol; 1998 Oct; 92(7):775-83. PubMed ID: 9924535
[TBL] [Abstract][Full Text] [Related]
14. Reduction of pathological findings in urine and bladder lesions in infection with Schistosoma haematobium after treatment with praziquantel.
Doehring E; Reider F; Schmidt-Ehry G; Ehrich JH
J Infect Dis; 1985 Oct; 152(4):807-10. PubMed ID: 3930620
[TBL] [Abstract][Full Text] [Related]
15. Impact of praziquantel mass drug administration campaign on prevalence and intensity of Schistosoma haemamtobium among school children in Bahi district, Tanzania.
Chaula SA; Tarimo DS
Tanzan J Health Res; 2014 Jan; 16(1):1-8. PubMed ID: 26867266
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
17. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].
Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP
Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity.
Reimert CM; Mshinda HM; Hatz CF; Kombe Y; Nkulila T; Poulsen LK; Christensen NO; Vennervald BJ
Am J Trop Med Hyg; 2000 Jan; 62(1):19-28. PubMed ID: 10761720
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.
King CH; Muchiri EM; Mungai P; Ouma JH; Kadzo H; Magak P; Koech DK
Am J Trop Med Hyg; 2002 Jun; 66(6):725-30. PubMed ID: 12224581
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an ultrasonographic score for urinary bladder morbidity in Schistosoma haematobium infection.
Medhat A; Zarzour A; Nafeh M; Shata T; Sweifie Y; Attia M; Helmy A; Shehata M; Zaki S; Mikhail N; Ibrahim S; King C; Strickland GT
Am J Trop Med Hyg; 1997 Jul; 57(1):16-9. PubMed ID: 9242311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
